Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

Literature DB >> 8938097

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

J D Klausner¹, V H Freedman, G Kaplan.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1996 PMID： 8938097 DOI： 10.1006/clin.1996.0181

Source DB: PubMed Journal: Clin Immunol Immunopathol ISSN： 0090-1229

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Transport of thalidomide by the human intestinal caco-2 monolayers.

Authors: Shufeng Zhou; Yan Li; Phillip Kestell; Peter Schafer; Eli Chan; James W Paxton
Journal: Eur J Drug Metab Pharmacokinet Date: 2005 Jan-Jun Impact factor: 2.441

Review 2. Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation.

Authors: S M McHugh; T L Rowland
Journal: Clin Exp Immunol Date: 1997-11 Impact factor: 4.330

3. Mycoplasma fermentans-induced inflammatory response of astrocytes: selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10.

Authors: R Gallily; M Kipper-Galperin; T Brenner
Journal: Inflammation Date: 1999-12 Impact factor: 4.092

Review 4. Thalidomide in cancer treatment: a potential role in the elderly?

Authors: Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal: Drugs Aging Date: 2002 Impact factor: 3.923

5. Targeting TNFα-mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study.

Authors: Abigail A Palmer; Jason P Stezoski; Keri Janesko-Feldman; Patrick M Kochanek; Tomas Drabek
Journal: Exp Ther Med Date: 2022-04-08 Impact factor: 2.447

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

1. Transport of thalidomide by the human intestinal caco-2 monolayers.

Review 2. Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation.

3. Mycoplasma fermentans-induced inflammatory response of astrocytes: selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10.

Review 4. Thalidomide in cancer treatment: a potential role in the elderly?

5. Targeting TNFα-mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study.

6. Thalidomide Promotes Morphine Efficacy and Prevents Morphine-Induced Tolerance in Rats with Diabetic Neuropathy.

7. Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Review 8. Management of spondyloarthropathy: new pharmacological treatment options.

9. Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis.

Review 10. Current Perspectives on Severe Drug Eruption.